𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application

✍ Scribed by Muhammad Furqan, Nikhil Mukhi, Byung Lee, Delong Liu

Book ID
119915165
Publisher
BioMed Central
Year
2013
Tongue
English
Weight
290 KB
Volume
1
Category
Article
ISSN
2050-7771

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

P110 Defect of JAK2/STAT5 signalling pat
P110 Defect of JAK2/STAT5 signalling pathway in essential thrombocythemia and myelofibrosis. (Hypothesis: Malignant Stem Cell transformation)
✍ E. Gulya; P. GombΓ‘s; A. KΓ‘rpΓ‘ti; K. KristΓ³; A. Matolcsy; Z. MΓ‘trai; K. Pecze πŸ“‚ Article πŸ“… 2007 πŸ› Elsevier Science 🌐 English βš– 52 KB

bicytopenia (anemia and thrombocytopenia). She is again transfusion dependent and on H1 and H2 blockers. Conclusion: Cladribine therapy is efficient in patient with systemic mastocytosis but response is transient so there is need for new therapy options in this rare hematologic disease. P110 Defect

Long-range effect of upd, a ligand for J
Long-range effect of upd, a ligand for Jak/STAT pathway, on cell cycle in Drosophila eye development
✍ Yu-Chen Tsai; Y. Henry Sun πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 976 KB

## Abstract __unpaired__ (__upd__) encodes a ligand for the Jak/STAT signaling pathway in __Drosophila__. In the second instar and early third larval eye disc, __upd__ is expressed in the center of the posterior margin. __upd__ loss‐of‐function mutations caused eye size reduction and __upd__ overex